Related Experiment Videos
[Cellulitis and necrotizing fasciitis: microbiology and pathogenesis]
1Service de Microbiologie, Centre National de Référence des Streptocoques, Hôtel-Dieu, Université Paris VI, Paris, France.
Annales De Dermatologie Et De Venereologie
|April 25, 2001
Summary
Streptococcus pyogenes and Staphylococcus aureus cause severe skin infections. Prompt antibiotic treatment, including clindamycin and broad-spectrum agents, alongside surgical debridement, is crucial for managing these polymicrobial infections and preventing organ failure.
Area of Science:
- Infectious Diseases
- Microbiology
- Dermatology
Background:
- Streptococcus pyogenes and Staphylococcus aureus are significant pathogens causing necrotizing cutaneous infections.
- Bacterial surface components (e.g., Protein M, capsule) and toxins (e.g., streptolysin O, pyrogenic exotoxins, toxic shock syndrome toxin) mediate adherence, invasiveness, and tissue damage.
- These infections can be polymicrobial, involving various anaerobes and other bacteria depending on the infection site.
Framework:
- Understanding the pathogenic mechanisms of Streptococcus pyogenes and Staphylococcus aureus, including their virulence factors.
- Identifying common co-infecting microorganisms like anaerobes (Peptostreptococcus, Prevotella, Porphyromonas, Fusobacterium) and enterobacteria.
- Recognizing the role of superantigens in toxic shock syndrome.
Implementation:
- Penicillin is the primary treatment for streptococcal infections, but clindamycin or other protein synthesis inhibitors are recommended for severe cases.
- Initial therapy must address potential co-infections with Staphylococcus aureus and anaerobes.
- Broad-spectrum antibiotics may be necessary for infections involving enterobacteria.
Implications:
- Effective management requires prompt and aggressive surgical exploration and debridement of infected tissues.
- Supportive care is essential for patients with shock and multiple organ failure.
- Timely and appropriate antibiotic selection is critical for successful patient outcomes in severe cutaneous infections.